Related Experiment Video
Updated: Oct 30, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Cancer Vaccines: Promising Therapeutics or an Unattainable Dream
Howard Donninger1,2, Chi Li1,3, John W Eaton2,4
1James Graham Brown Cancer Center, Experimental Therapeutics Group, University of Louisville, Louisville, KY 40202, USA.
Abstract:
The advent of cancer immunotherapy has revolutionized the field of cancer treatment and offers cancer patients new hope. Although this therapy has proved highly successful for some patients, its efficacy is not all encompassing and several cancer types do not respond. Cancer vaccines offer an alternate approach to promote anti-tumor immunity that differ in their mode of action from antibody-based therapies. Cancer vaccines serve to balance the equilibrium of the crosstalk between the tumor cells and the host immune system. Recent advances in understanding the nature of tumor-mediated tolerogenicity and antigen presentation has aided in the identification of tumor antigens that have the potential to enhance anti-tumor immunity. Cancer vaccines can either be prophylactic (preventative) or therapeutic (curative). An exciting option for therapeutic vaccines is the emergence of personalized vaccines, which are tailor-made and specific for tumor type and individual patient. This review summarizes the current standing of the most promising vaccine strategies with respect to their development and clinical efficacy. We also discuss prospects for future development of stem cell-based prophylactic vaccines.
Insights
Cancer vaccines offer a promising alternative to immunotherapy by stimulating anti-tumor immunity. Personalized cancer vaccines are emerging as a key therapeutic strategy for various cancer types.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cancer immunotherapy has transformed treatment but lacks universal efficacy.
- Several cancer types exhibit resistance to current immunotherapies.
- Cancer vaccines present an alternative strategy to enhance anti-tumor immune responses.
Purpose of the Study:
- To review current cancer vaccine strategies and their clinical efficacy.
- To explore the potential of personalized cancer vaccines.
- To discuss future directions, including stem cell-based vaccines.
Main Methods:
- Review of recent advances in understanding tumor immunology and antigen presentation.
- Analysis of current cancer vaccine development and clinical trial data.
- Discussion of emerging vaccine technologies and future prospects.
Main Results:
- Cancer vaccines modulate the tumor-immune system interaction to promote anti-tumor immunity.
- Advances in antigen identification enhance vaccine potential.
- Personalized vaccines offer tailored therapeutic options.
Conclusions:
- Cancer vaccines represent a significant advancement in cancer treatment.
- Personalized and stem cell-based vaccines hold considerable promise for future development.
- Further research is needed to optimize vaccine efficacy across diverse cancer types.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Prevention
Some...

